Accordingly, in human colorectal cancer cell lines, CD155 expression provides a proliferative advantage to the tumor while its knockdown shifts Bax/Bcl-2 balance towards pro-apoptotic signaling [42]. This evidence concerns the gene PVR and neoplasm.